Literature DB >> 23736001

Progress and prospects in stem cell therapy and drug discovery.

Qi Zhou.   

Abstract

Mesh：

Year:  2013        PMID： 23736001      PMCID： PMC4002900          DOI： 10.1038/aps.2013.72

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN： 1671-4083            Impact factor:   6.150


× No keyword cloud information.
  14 in total

Review 1.  Roles of small molecules in somatic cell reprogramming.

Authors:  Jian-bin Su; Duan-qing Pei; Bao-ming Qin
Journal:  Acta Pharmacol Sin       Date:  2013-06-03       Impact factor: 6.150

Review 2.  Stem cell signaling as a target for novel drug discovery: recent progress in the WNT and Hedgehog pathways.

Authors:  Songzhu Michael An; Qiang Peter Ding; Ling-song Li
Journal:  Acta Pharmacol Sin       Date:  2013-05-27       Impact factor: 6.150

Review 3.  Stem cells and small molecule screening: haploid embryonic stem cells as a new tool.

Authors:  Bi Wu; Wei Li; Liu Wang; Zhong-hua Liu; Xiao-yang Zhao
Journal:  Acta Pharmacol Sin       Date:  2013-05-06       Impact factor: 6.150

Review 4.  Human pluripotent stem cells for disease modelling and drug screening.

Authors:  Yves Maury; Morgane Gauthier; Marc Peschanski; Cécile Martinat
Journal:  Bioessays       Date:  2011-10-28       Impact factor: 4.345

5.  Mesenchymal stem cells transplantation suppresses inflammatory responses in global cerebral ischemia: contribution of TNF-α-induced protein 6.

Authors:  Qing-ming Lin; Shen Zhao; Li-li Zhou; Xiang-shao Fang; Yue Fu; Zi-tong Huang
Journal:  Acta Pharmacol Sin       Date:  2013-03-11       Impact factor: 6.150

Review 6.  iPSCs and small molecules: a reciprocal effort towards better approaches for drug discovery.

Authors:  Ru Zhang; Li-hong Zhang; Xin Xie
Journal:  Acta Pharmacol Sin       Date:  2013-04-22       Impact factor: 6.150

7.  Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin.

Authors:  Jacob Hanna; Marius Wernig; Styliani Markoulaki; Chiao-Wang Sun; Alexander Meissner; John P Cassady; Caroline Beard; Tobias Brambrink; Li-Chen Wu; Tim M Townes; Rudolf Jaenisch
Journal:  Science       Date:  2007-12-06       Impact factor: 47.728

8.  Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds.

Authors:  Danwei Huangfu; René Maehr; Wenjun Guo; Astrid Eijkelenboom; Melinda Snitow; Alice E Chen; Douglas A Melton
Journal:  Nat Biotechnol       Date:  2008-06-22       Impact factor: 54.908

Review 9.  Disease modeling and drug screening for neurological diseases using human induced pluripotent stem cells.

Authors:  Xiao-hong Xu; Zhong Zhong
Journal:  Acta Pharmacol Sin       Date:  2013-05-20       Impact factor: 6.150

10.  Identification of a small molecule 1,4-bis-[4-(3-phenoxy-propoxy)-but-2-ynyl]-piperazine as a novel inhibitor of the transcription factor p53.

Authors:  Xin Liu; Ying Zhang; Man Tong; Xiu-ying Liu; Guan-zheng Luo; Dong-fang Xie; Shao-fang Ren; Dong-hui Bai; Liu Wang; Qi Zhou; Xiu-jie Wang
Journal:  Acta Pharmacol Sin       Date:  2013-06       Impact factor: 6.150
View more
  1 in total

1.  Expression profiles of histone lysine demethylases during cardiomyocyte differentiation of mouse embryonic stem cells.

Authors:  Yan Tang; Zhong-Yan Chen; Ya-Zhen Hong; Qiang Wu; Han-Qing Lin; Charlie Degui Chen; Huang-Tian Yang
Journal:  Acta Pharmacol Sin       Date:  2014-07       Impact factor: 6.150
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.